|Master Investor Magazine
Never miss an issue of Master Investor Magazine – sign-up now for free!
AIM-listed pharmaceutical firm Shield Therapeutics (LON:STX) has seen its share price drop by 3.55% to 109.55p (as of 13:05 BST) after legal proceedings were lodged against it. Teva Pharmaceuticals has filed an appeal to the Opposition Division of the European Patent Office regarding the decision on a patent held by Shield.
Management said that the company will defend its intellectual property and believe that the board of appeal should uphold the original decision.
The Master Investor Show 2020 tickets are now available. Join us at the Business Design Centre on Saturday 28 March 2020.
Book your FREE tickets today using code: MIBLOG